The KNSTRN Knouckout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population featuring targeted disruption of the KNSTRN gene in the well-established Jurkat human T lymphocyte cell line. This loss-of-function model employs CRISPR/Cas9-mediated gene disruption to eliminate functional KNSTRN protein expression, providing a valuable tool for dissecting kinetochore biology in a leukemic background. As a polyclonal population, these cells offer a heterogeneous yet robust knockout system suitable for functional assays without clonal artifacts.
The Jurkat cell line, an immortalized suspension cell line derived from a 14-year-old male with acute T cell leukemia, is extensively utilized in T cell receptor signaling and apoptosis research. Its rapid proliferation and genetic tractability make it an ideal host for generating knockout models to investigate mitotic mechanisms in transformed T cells. The parental Jurkat background provides a relevant context for exploring how disruptions in chromosome segregation contribute to leukemic progression and genomic instability.
KNSTRN encodes a kinetochore protein that acts as a central scaffold for the MIS12 and NDC80 complexes, which are essential for establishing end-on microtubule attachments and silencing the spindle assembly checkpoint during mitosis. Its activity is tightly controlled by mitotic kinases CDK1, PLK1, and AURKB, and it engages with ZWINT, KNL1, and the motor protein CENP-E to orchestrate accurate chromosome congression. Disruption of KNSTRN destabilizes the KMN network (KNL1-MIS12-NDC80), causing defective kinetochore-microtubule coupling, prolonged SAC activation, and chromosome missegregation, which ultimately drive aneuploidy.
In the Jurkat T cell leukemia model, KNSTRN knockout creates a valuable tool for dissecting the relationship between mitotic errors and malignant transformation. By abolishing KNSTRN function, researchers can directly examine how spindle checkpoint failure contributes to the chromosomal instability observed in cancers such as melanoma and other malignancies. The polyclonal knockout population enables the study of heterogeneous cellular responses and the identification of compensatory pathways that leukemic cells might activate to cope with increased chromosome missegregation, offering insights into potential therapeutic interventions.
Typical experimental approaches include Western blotting for mitotic markers like phospho-histone H3, immunofluorescence imaging of chromosome alignment using ??-tubulin and CREST antibodies, and flow cytometry-based cell cycle profiling. Live-cell imaging captures real-time mitotic defects, while co-immunoprecipitation verifies the integrity of kinetochore subcomplexes. These methods facilitate antimitotic drug screens and research into aneuploidy in hematological contexts. For detailed protocols and support, please contact Ascent Research.
